Skip to main content
CTVA
NYSE Industrial Applications And Services

Corteva Settles North Carolina PFAS Claims for $66M Share of $455M Deal

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Neutral
Importance info
8
Price
$84.75
Mkt Cap
$56.545B
52W Low
$60.535
52W High
$90.97
52W Position info
40% above low
Off High info
6.8% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

CTVA sits 40% above its 52-week low of $60.535.

Summary

Corteva settled North Carolina PFAS litigation with a $66M direct share of a $455M deal, plus a 29% guarantee of Chemours' payments and a $135M reserve fund backstop.


Key Events · Legal and Risk Events · CTVA

  • North Carolina PFAS Settlement

    Corteva, DuPont, and Chemours agreed to pay $455M over 15 years to resolve statewide PFAS claims; Corteva's direct share is approximately $66M (14.5% of the total).

  • Chemours Payment Guarantee

    Corteva and DuPont must guarantee Chemours' settlement share on a 29%/71% basis if Chemours defaults, adding contingent liability beyond Corteva's direct payment.

  • $135M Reserve Fund Backstop

    Corteva and DuPont must establish a $135M reserve fund via line of credit, letter of credit, or surety bond to secure Chemours' remaining NC Consent Order obligations; Corteva's share is 29%.

  • MOU Cap Restructured

    The settlement applies $210M NPV against the $4B MOU qualified spend cap using an 8% discount rate over 25 years, and future MOU escrow contributions are deemed satisfied.


Analysis · CTVA · Industrial Applications And Services

A comprehensive settlement with North Carolina resolves statewide PFAS claims tied to the Fayetteville Works site for Corteva, DuPont, and Chemours. Corteva's direct payment share is approximately $66 million over 15 years, but the larger exposure is the guarantee obligation: Corteva and DuPont must backstop Chemours' settlement payments on a 29%/71% basis and fund a $135 million reserve facility to secure Chemours' remaining obligations under the 2019 NC Consent Order. The settlement also restructures the MOU economics — applying a $210 million net present value against the $4 billion qualified spend cap and eliminating future escrow contributions. This removes a major multi-year litigation overhang while adding contingent financial obligations that could materialize if Chemours defaults.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CTVA was trading at $84.75 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $56.5B. The 52-week trading range was $60.54 to $90.97. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CTVA - Latest Insights

CTVA
Nov 12, 2026, 5:12 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.26
Real-time Price: $9.37 info
Change: +$0.110 (+1%) info
Market Cap: $6.293B info
CTVA
Nov 12, 2026, 11:47 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $9.82
Real-time Price: $9.37 info
Change: -$0.445 (-5%) info
Market Cap: $6.293B info
CTVA
Nov 12, 2026, 8:34 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.89
Real-time Price: $9.37 info
Change: -$1.52 (-14%) info
Market Cap: $6.293B info
CTVA
Nov 12, 2026, 5:45 AM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $10.89
Real-time Price: $9.37 info
Change: -$1.52 (-14%) info
Market Cap: $6.293B info
CTVA
Nov 11, 2026, 4:30 PM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $12.19
Real-time Price: $9.37 info
Change: -$2.82 (-23%) info
Market Cap: $6.293B info